Conflict of Interest Disclosures for AAGP Board Members, Committee Chairs, and Executive Staff
Board of Directors
Allan A. Anderson, MD, President
AAGP Compensation: Honorarium for review course at annual meeting (in the past).
Governance: Serve on APA RBRVS Committee and Alt. Rep to AMA RUC.
Research Support: Clinical Trials support from Novartis, Medivation and Lilly.
Financial: Past Speaker Honoraria – Novartis, Pfizer, Forest (> 1 year ago)
Paul D.S. Kirwin, MD, President-Elect
Governance: ABPN Geriatric Committee.
Consulting: Global Medical Advisory Board, Americares (non-paid).
Jeffrey M. Lyness, MD, Past President
Research support: NIMH
Susan K. Schultz, MD, Secretary/Treasurer
Research Support: NIA-funded Alzheimer’s Disease Cooperative Study partnership with Baxter Healthcare. NCI-funded research grant.
Financial Compensation: American Psychiatric Association – compensation for editorial duties for the American Journal of Psychiatry and DSM-5; American Academy of Clinical Psychiatrists – honorarium for two symposia, 2011.
Josepha A. Cheong, MD, Secretary/Treasurer-Elect
AAGP Compensation: March 2011, received a travel stipend and honorarium with Educator Award (prior to start of board service).
Governance: ABPN – Question Writing Team for Geriatric Psychiatry. APA – Scientific Program Committee.
Financial Compensation: US Veterans Health Administration – Gainesville VAMC – staff physician salary. University of Florida College of Medicine – faculty salary support
Iqbal "Ike" Ahmed, MD, Board Member
Governance – Member of Geriatric Psychiatry Exam writing committee of ABPN; Member of the APA Assembly.
Patricia A. Arean, PhD, Board Member
Governance: American Psychological Association Committee on Aging; American Psychological Association Treatment Guidelines Advisory Committee; Chair, NIMH Services Research: Special Populations study section
Brent P. Forester, MD, Board Member
Grant Support: NIMH, Glaxo SmithKline, Rogers Family Foundation, NARSAD
Financial: Speaker’s Bureau – Pfizer, Eli Lilly, AstraZeneca, and Novartis – all ended 2009.
Governance: Board member, Alzheimer’s Association for MA/NH
Consultant: Repligen (ended in January 2010)
Blaine S. Greenwald, MD, Board Member
Governance: Board of Directors, Long Island Chapter of the Alzheimer’s Association
Financial: Boehringer-Ingelheim speaking honoraria (1 lecture, 3/09; 1 lecture 3/10)
Maria D. Llorente, MD, Board Member
Governance: Member, Council on Adult Psychiatry, American Psychiatric Association; Member of Geriatric Psychiatry Certification/Recertification Exam writing committee of ABPN
Financial: Consultant to Medical Directions, Inc (on-line CME company)
Research Support: Dept. of Veterans Affairs HSR&D
Constantine G. Lyketsos, MD, MHS, Board Member
Consultant/Advisor: Astra-Zeneca, Glaxo-Smith Kline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck, Merz, Lilly, Pfizer, Genentech, Elan, NFL Players Association, NFL Benefits Office.
Honorarium or travel support: Pfizer, Forest, Glaxo-Smith-Kline, Health Monitor.
Grant Support: (Research or CME) NIMH, NIA, Associated Jewish Federation of Baltimore, Weinberg Foundation, Forest, Glaxo-Smith-Kline, Eisai, Pfizer, Astra-Zeneca, Lilly, Ortho-McNeil, Bristol-Myers, Novartis, National Football League, Elan
Amita R. Patel, MD, CMD, MHA, CPE, Board Member
Financial: Speakers Bureau – Lilly, BMS, Pfizer, Novartis, AstraZeneca, Sunovion, Pamlabs
Daniel D. Sewell, MD, Board Member
Financial: CEO of TEP, Inc. This is an s-corp that among other things is primarily involved in preparing and delivering educational presentations. As long as I am a board member, TEP, Inc. will not do business directly with the AAGP, but at the recent annual meeting TEP Inc. received payment from CME Outfitters for my role in an ISS.
Research Support: Hartford Foundation for role as the associate director of the physician-educator track which is part of our Geropsychiatry Center of Excellence. I also receive a modest amount of funding from an NIH grant for which Dilip Jeste is the PI.
Other: Uncompensated member of the medical advisory board of the George G. Glenner Alzheimer’s Family Centers Inc. Unpaid member of the medical and scientific advisory board of the San Diego/Imperial Chapter of the Alzheimer’s Association. Member of the medical advisory board of the San Diego chapter of the National Alliance for the Mentally Ill.
Honoraria: I receive an honoraria for serving on the Medical Advisory Board of the Healthcare Group, Inc. I receive occasional honoraria from the American Geriatrics Society for articles which I have written for publication in the journal Clinical Geriatrics. I received an honoraria for a chapter that was included in the 9th Edition of Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, published by LWW.
Larry Tune, MD, Board Member
Research Support: Pfizer/Eisai – site PI on grant studying new formulation of Aricept
Ellen Whyte, MD, Board Member
Research Support: Contract with Fox Learning Systems to conduct the study outlined in their NIH funded SBIR grant (ended 12/31/2010). NICHD-NCMRR – this NIH agency is the funder of my current R01 study. Recent recipient of an investigator initiated research grant underwritten by Forest Pharmaceuticals (grant ended 2010).
Laurie Boore, MD, MIT Board Member
Nothing to Disclose.
Robert M. Greenberg, MD, Clinical Practice Committee Co-Chair
No conflicts to disclose.
Barbara Kamholz, MD, CME Committee Chair
No conflicts to disclose.
Maureen C. Nash, MD, MS, Clinical Practice Committee Co-Chair
Call MD – Provide on call services; ePocrates – answer surveys; Pacific University, Alzheimer’s Association of OR – honoraria for lectures.
Jordan F. Karp, MD, Diversity Committee Co-Chair
Research Support: Receipt of medication supplies for investigator-initiated trials from Eli Lilly, Pfizer, Reckitt Benckiser. Grant support from NIH, RAND, NARSAD
Financial: Own stock in Corcept. Honoraria for education activity – Novartis.
Advisor: Theravance (>1 year ago); Eli Lilly (resigned >1 year ago)
Karen Blank, MD, Public Policy and Communications Committee Chair
No conflicts to disclose.
Eric Lenze, MD, Research Committee Chair
Research Support: Forest Laboratories. Medication-only agreement for research from Pfizer and BMS.
Other: Rite-Aid, approx.. $5,000 stock holdings
Christine M. deVries, Chief Executive Officer / Executive Vice-President
Marjorie Vanderbilt, Deputy Executive Director/Director, Govt. Affairs
Carrie Stankiewicz, Director of Governance